Dr. Douglas Reznick shares advice for patients with lung or head and neck cancer who may feel overwhelmed by their diagnosis.

A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...

A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...

When Paul Hall was diagnosed with stage 4 lung cancer in October 2021, he said, “I’m not quitting.” ...

Although immunotherapies and biomarker-driven interventions have transformed lung cancer outcomes, Martin Edelman, MD, Fox Chase Cancer Center, highlighted the present challenge hindering clinicians' ...

They are available to provide support to patients, their families, doctors, and other members of the care team. Samantha Murrell shares her journey with stage 4 NSCLC, a form of lung cancer. From her ...

Case Demonstrates Benefit of Integrating CyPath ® Lung into Standard of Care for Patients Under Surveillance After Treatment for Previous Lung Cancer SAN ANTONIO, March 26, 2025--(BUSINESS WIRE ...

In final draft guidance on Opdivo (nivolumab) in non-small cell lung cancer, which applies to England and Wales, NICE said the drug could be recommended for patients who express high levels of PD ...

Most patients who enroll in the Lung-MAP precision medicine trial in non-small cell lung cancer can now be matched to a targeted investigational treatment based on the results of their prior genomic ...

Efti's unique MHC Class 2 agonist mechanism shows strong efficacy and safety across PD-L1 levels in lung cancer trials. The trial will enroll 756 patients globally, with randomization to treatment or ...

HONOLULU (KHON2) — Hawaii has ranked last in the nation for early diagnosis of lung cancer for three straight years. But the Queen’s Health Systems is looking to change that with the launch of ...